Skip to main content

Publisher: Elsevier

Volume 3, Number 1, February 2003

Editorial board
pp. i-i(1)

Favourites:
ADD

Contents
pp. iii-iii(1)

Favourites:
ADD
Favourites:
ADD

Treatment options for status epilepticus
pp. 6-11(6)
Author: Lowenstein, D.H.

Favourites:
ADD

GABAA receptor function and pharmacology in epilepsy and status epilepticus
pp. 12-18(7)
Authors: Jones-Davis, D.M.; Macdonald, R.L.

Favourites:
ADD

Recent developments from genetic mouse models of seizures
pp. 19-26(8)
Authors: Upton, N.; Stratton, S.

Favourites:
ADD

Pharmacology of traumatic brain injury
pp. 27-32(6)
Authors: Royo, N.; Shimizu, S.; Schouten, J.; Stover, J.; McIntosh, T.

Favourites:
ADD
Favourites:
ADD

GDNF and somatostatin in sensory neurones
pp. 41-45(5)
Author: Malcangio, M.

Favourites:
ADD
Favourites:
ADD

CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?
pp. 62-67(6)
Authors: Malan, T.P.; Ibrahim, M.M.; Lai, J.; Vanderah, T.W.; Makriyannis, A.; Porreca, F.

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Cytokines: regulation of the hypothalamo-pituitary-adrenocortical axis
pp. 78-84(7)
Authors: John, C.D.; Buckingham, J.C.

Favourites:
ADD

The MCH receptor family: feeding brain disorders?
pp. 85-89(5)
Author: Forray, C.

Favourites:
ADD

Trace amine receptors as targets for novel therapeutics: legend, myth and fact
pp. 90-97(8)
Authors: Branchek, T.A.; Blackburn, T.P.

Favourites:
ADD

Active drug metabolites in drug development
pp. 98-100(3)
Author: Gad, S.C.

Favourites:
ADD
Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more